Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Glatting

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Zeitschrift Fur Medizinische Physik|March 21, 2015
The NUKDOS software for treatment planning in molecular radiotherapyPeter Kletting, Sebastian Schimmel, Heribert Hänscheid, et al.
EJNMMI Physics|October 13, 2025
<sup>131</sup>I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection with non-linear mixed-effects modellingDeni Hardiansyah, Ade Riana, Heribert Hänscheid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
The role of patient-based treatment planning in peptide receptor radionuclide therapyDeni Hardiansyah, Christian Maass, Ali Asgar Attarwala, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [<sup>177</sup>Lu]Lu-PSMA-617 TherapyDeni Hardiansyah, Elham Yousefzadeh-Nowshahr, Felix Kind, et al.
Zeitschrift Fur Medizinische Physik|April 17, 2017
Investigation of the imaging characteristics of the ALBIRA II small animal PET system for <sup>18</sup>F, <sup>68</sup>Ga and <sup>64</sup>CuAli Asgar Attarwala, Yvonne Wanjiku Karanja, Deni Hardiansyah, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in <sup>177</sup>Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized TreatmentLuis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, et al.
Medical Physics|May 12, 2017
Internal radionuclide therapy: The ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Medical Physics|August 27, 2005
Internal radionuclide therapy: the ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Annals of Nuclear Medicine|November 12, 2020
Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for <sup>99m</sup>Tc imagingAli Asgar Attarwala, Deni Hardiansyah, Chiara Romanó, et al.
Medical Physics|November 27, 2020
Important pharmacokinetic parameters for individualization of <sup>177</sup> Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic modelDeni Hardiansyah, Peter Kletting, Nusrat J Begum, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Zeitschrift Fur Medizinische Physik|March 21, 2015
The NUKDOS software for treatment planning in molecular radiotherapyPeter Kletting, Sebastian Schimmel, Heribert Hänscheid, et al.
EJNMMI Physics|October 13, 2025
<sup>131</sup>I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection with non-linear mixed-effects modellingDeni Hardiansyah, Ade Riana, Heribert Hänscheid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
The role of patient-based treatment planning in peptide receptor radionuclide therapyDeni Hardiansyah, Christian Maass, Ali Asgar Attarwala, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [<sup>177</sup>Lu]Lu-PSMA-617 TherapyDeni Hardiansyah, Elham Yousefzadeh-Nowshahr, Felix Kind, et al.
Zeitschrift Fur Medizinische Physik|April 17, 2017
Investigation of the imaging characteristics of the ALBIRA II small animal PET system for <sup>18</sup>F, <sup>68</sup>Ga and <sup>64</sup>CuAli Asgar Attarwala, Yvonne Wanjiku Karanja, Deni Hardiansyah, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in <sup>177</sup>Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized TreatmentLuis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, et al.
Medical Physics|May 12, 2017
Internal radionuclide therapy: The ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Medical Physics|August 27, 2005
Internal radionuclide therapy: the ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Annals of Nuclear Medicine|November 12, 2020
Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for <sup>99m</sup>Tc imagingAli Asgar Attarwala, Deni Hardiansyah, Chiara Romanó, et al.
Medical Physics|November 27, 2020
Important pharmacokinetic parameters for individualization of <sup>177</sup> Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic modelDeni Hardiansyah, Peter Kletting, Nusrat J Begum, et al.
Pageof 15